https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/accounts-payable https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/accounts-payable-other-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/accounts-receivable https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/accounts-receivable-from-securitization https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/accounts-receivable-gross https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/accounts-receivable-net https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/accrued-salaries-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/accumulated-depreciation https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/acquired-financial-assets https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/acquired-financial-liabilities https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/acquired-inventory https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/acquired-property-plant-and-equipment https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/acquisition-step-acquisition-equity-interest-in-acquiree-percentage https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/additional-paid-in-capital https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/adjustments-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/advances-to-affiliate https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/allowance-for-doubtful-accounts-receivable-change https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/amortization https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/aoci https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/basic-shares https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/buildings-and-improvements-gross https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/business-acquisition-cost-of-acquired-entity-cash-paid https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/business-acquisition-cost-of-acquired-entity-other-noncash-consideration https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/capital-expenditures https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/cash-and-equivalents https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/cash-flow-breakdown https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/common-stock-value https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/construction-in-progress-gross https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/cost-of-goods-sold-depreciation https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/cost-of-revenue https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/current-assets https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/current-liabilities https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/debt-related-commitment-fees-and-debt-issuance-costs https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/deferred-revenue https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-allowance-for-doubtful-accounts https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/deposits https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/depreciation https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/depreciation-and-amortization https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/diluted-shares https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/dividends-preferred-stock https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/due-from-related-parties-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/due-to-related-parties-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/eps https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/eps-basic https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/equity-method-investment-summarized-financial-information-net-income-loss https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/financing-cash-flow https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/form-d-other https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/general-and-administrative-expense https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/goodwill https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/gross-profit https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/income-taxes-paid https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/increase-decrease-in-other-accounts-payable https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/increase-decrease-in-postemployment-obligations https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/incremental-common-shares-attributable-to-written-put-options https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/indefinite-lived-contractual-rights https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/insider-transactions-other https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/interest-and-dividends-payable-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/interest-paid https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/inventory https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/inventory-finished-goods https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/inventory-raw-materials https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/inventory-work-in-process https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/investing-cash-flow https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/investment-income-interest https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/investments-and-other-noncurrent-assets https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/loans-payable-to-bank-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/long-term-loans-from-bank https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/longterm-debt-weighted-average-interest-rate https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/net-change-in-cash https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/net-income https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/number-of-operating-segments https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/number-of-stores https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/oci-net-of-tax-change https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/operating-cash-flow https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/operating-expenses https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/operating-income https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/operating-lease-payments-due https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/other-additional-capital https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/other-current-assets https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/other-income https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/other-loans-payable-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/other-nonoperating-expense https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/other-nonoperating-income https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/other-receivables https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/paid-in-capital-other https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/payments-for-deposits-with-other-institutions https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/payments-of-dividends-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/payments-to-acquire-other-investments https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/payments-to-acquire-other-property-plant-and-equipment https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/postemployment-benefits-liability-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/postemployment-benefits-liability-noncurrent https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/preferred-shares-facts https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/preferred-stock-accretion-of-redemption-discount https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/preferred-stock-dividends-and-other-adjustments https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/preferred-stock-value https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/proceeds-from-bank-debt https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/proceeds-from-issuance-of-other-long-term-debt https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/proceeds-from-repayments-of-lines-of-credit https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/proceeds-from-repayments-of-other-long-term-debt https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/proceeds-from-repayments-of-restricted-cash-financing-activities https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/proceeds-from-sale-of-machinery-and-equipment https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/profit-loss https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/property-plant-equipment https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/public-float https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/receivables-net-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/repayments-of-bank-debt https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/retained-earnings https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/revenue https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/revenues-from-external-customers https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/sales-revenue-goods-net-percentage https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/secured-debt https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/segment-reporting-information-net-assets https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/selling-expense https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/shareholders-equity https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/shares-authorized https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/shares-issued https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/shares-outstanding-2 https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/shipping-handling-and-transportation-costs https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/short-term-borrowings https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/short-term-debt https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/short-term-debt-weighted-average-interest-rate https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-based-compensation https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stockholders-equity-other https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/stockholders-equity-other-shares https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/taxes-payable-current https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/temporary-equity-value-excluding-additional-paid-in-capital https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/total-assets https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/total-liabilities https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/total-long-term-debt https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/china-bct-pharmacy-group-inc/weighted-average-number-of-share-outstanding-basic-and-diluted